A New Alternative for
Testing Central Venous
Catheters (CVCs) for
Catheter Related Blood
Stream Infections (CRBSIs).

The high incidence of CRBSIs, and the potential for morbidity and mortality related to CVC use, have put the prevention of central line infections at the forefront of US national health care (1). It is one of the six initiatives implemented by the Institute of Healthcare Improvement’s 100,000 Lives Campaign.

Approximately 250,000 cases of CRBSI are estimated to occur in the US with attributable mortality estimated at 12%-25% for each infection, and cost to the healthcare system is estimated to be $25,000 per episode (1).

CDC guidelines include not replacing catheters routinely for prevention of infection or for fever alone (1).

The FACTS™ procedure offers a simple and economical way to test a CVC for sepsis while it remains in-situ (in the patient), preventing the unnecessary removal and replacement of central venous catheters thus reducing costs and improving patient outcomes (3).

The FACTS™ Kit includes everything needed to conduct a reliable test for CRBSI.

Here is how FACTS™ works -











Page 1 | 2
1. CDC. (2002). Guidelines for the prevention of intravascular catheter-related infections.
Morbidity and Mortality Weekly Report, 51.
2. Mermel, L.A., et al. (2001). Guidelines for management of intravascular catheter-related
infections. Journal of Infusion Nursing, 24(3).
3. Catton, J., et. al. 2002. Quantitative culture of through line blood is an accurate
method for the diagnosis of central venous catheter-related bloodstream infection
without catheter removal. 26th Clinical Congress of Nutrition Practice.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 




 

 

 

 

 

 

 

 

 

 

 

More about FACTS™ >>